Shares of DocGo Inc. (NASDAQ:DCGO – Get Free Report) have earned an average recommendation of “Hold” from the six brokerages that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $2.3750.
DCGO has been the topic of several recent analyst reports. Stifel Nicolaus dropped their target price on shares of DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a report on Tuesday, March 17th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a report on Thursday. Cantor Fitzgerald reiterated an “overweight” rating on shares of DocGo in a report on Monday, May 11th. Needham & Company LLC reiterated a “buy” rating and issued a $3.00 target price on shares of DocGo in a report on Tuesday, March 17th. Finally, Canaccord Genuity Group dropped their target price on shares of DocGo from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Wednesday, March 25th.
Get Our Latest Stock Report on DocGo
Institutional Trading of DocGo
DocGo Price Performance
Shares of DCGO opened at $0.53 on Thursday. The company has a market capitalization of $52.67 million, a PE ratio of -0.28 and a beta of 1.00. DocGo has a one year low of $0.49 and a one year high of $1.78. The company’s fifty day moving average price is $0.61 and its 200 day moving average price is $0.72.
DocGo (NASDAQ:DCGO – Get Free Report) last announced its earnings results on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.10). The firm had revenue of $75.55 million during the quarter, compared to the consensus estimate of $72.48 million. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%. Analysts anticipate that DocGo will post -0.12 earnings per share for the current year.
About DocGo
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
